Loading News...
Back to Dashboard

Johnson & Johnson (JNJ)

Real-time intraday values

Market Overview

From:
To:
JNJ Intraday
No data available
SymbolJNJ
IPO DateJan 2, 1962
CEOMr. Joaquin Duato
Full Time Employees138.2k
SectorHealthcare
IndustryDrug Manufacturers - General
CountryUnited States
ExchangeNYSE
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Performance
PeriodReturn %Value Change
1 Day
-1.41%
-3.77 US$
5 Days
+3.24%
+8.28 US$
1 Month
-1.98%
-5.33 US$
6 Months
+15.97%
+36.34 US$

Analyzing Market with AI

Evaluating the last 30 days of history and fundamental metrics of JNJ...

Key Statistics
Market Cap
635.07B
P/E Ratio
40.03
Div Yield
2.03%
52W High
$281.07
52W Low
$184.66

Analyst Consensus

ConsensusBuy
Bullish1669.6%
Neutral626.1%
Bearish14.3%

52W Analyst Price Targets

Min Target
$190.00
Max Target
$320.00
Current$263.84
Avg Target$279.41

Analyst Recommendations

Target Price:$279.41($190.00 - $320.00)
FirmRatingTarget PriceUpside PotentialDate
Wells FargoOverweight$287.00+8.78%10/16/2026
Morgan StanleyOverweight$292.00+10.67%10/15/2026
Leerink PartnersOutperform$272.00+3.09%10/14/2026
Wells FargoOverweight$275.00+4.23%10/14/2026
RBC CapitalOutperform$280.00+6.12%10/14/2026
GuggenheimBuy$287.00+8.78%10/7/2026
RBC CapitalOutperform$290.00+9.92%10/6/2026
CitigroupBuy$303.00+14.84%10/5/2026
JP MorganNeutral$285.00+8.02%9/29/2026
HSBCBuy$320.00+21.29%9/10/2026
Community Thoughts

Share your analysis and sentiment on JNJ

Join the community to share your analysis